Can-Fite BioPharma
Israel - Petach TikvaPharmaceutical
Focus: Can-Fite BioPharma is an Israeli small-molecule biotech focused on adenosine receptor agonists across immunology, infectious disease, oncology, ophthalmology, and cardiovascular indications. The company operates as a clinical-stage developer with a broad pipeline spanning Phase 2 to Phase 3 programs.
Profile data last refreshed 11h ago · AI intelligence enriched 2w ago
Open Jobs
0
About Can-Fite BioPharma
AI assessmentNot HiringNo open roles listed right now. Follow Can-Fite BioPharma to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthStrong
Pipeline
Late-stage
5 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
CF 102
Chronic Hepatitis CClinical Trials (1)
NCT00790673A Phase 1/2 Study of CF102 in Patients With Chronic Hepatitis C Genotype 1
Phase 1/2Help build intelligence for Can-Fite BioPharma
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.